Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GLGC Gene Logic -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (343)	9/14/2007 3:00:02 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 360

Gene Logic Collaborates with FDA to Explore Genomic Data Quality Metrics Related to Drug Candidate Safety and Effectiveness phx.corporate-ir.net snip The Company has processed more than 200,000 microarrays to obtain genomic data and has developed proprietary methods and software to ensure those data are accurate, including more than 40 quality metrics. snp They use Affymetrix GeneChip® Arrays genelogic.com (apparently another 50,000 arrays since that brochure was last updated)